May 22 (Reuters) - Avecho Biotechnology Ltd AVE.AX :
* SIGNED A LICENSING AND DEVELOPMENT AGREEMENT WITH ARTHUR
GROUP
LLC
* AGREEMENT INCLUDES RIGHTS TO FIVE SEPARATE ONCOLOGY
PRODUCTS,
REPRESENTING COMBINED US MARKET OF US$2.92 BILLION
* AGREEMENT FOR FOR DEVELOPMENT OF A SERIES OF LEADING
CANCER
DRUGS
* UNDER DEAL, AVECHO WILL RECEIVE 30% OF REVENUE FROM
LICENSING
AND 30% OF NET PROFIT FROM COMMERCIALISATION OF PRODUCTS
Source text for Eikon: ID:nASX8zntWH
Further company coverage: AVE.AX
((Reuters.Briefs@thomsonreuters.com;))